Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey

Abstract This study explored the acceptability of a novel pharmacist‐led pharmacogenetics (PGx) screening program among patients with cancer and healthcare professionals (HCPs) taking part in a multicenter clinical trial of PGx testing (PACIFIC‐PGx ANZCTR:12621000251820). Medical oncologists, oncolo...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Sarah Glewis, Mei Krishnasamy, Senthil Lingaratnam, Sam Harris, Craig Underhill, Chloe Georgiou, Mark Warren, Robert Campbell, Maarten IJzerman, Mussab Fagery, Ian Campbell, Jennifer H. Martin, Jeanne Tie, Marliese Alexander, Michael Michael
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2023-12-01
Cyfres:	Clinical and Translational Science
Mynediad Ar-lein:	https://doi.org/10.1111/cts.13664
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!